Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) [Phase 2]
Phase 2 trial of A-dmDT390-bisFv(UCHT1) immunotoxin for cutaneous T-cell lymphoma (CTCL) has completed, with results from the study summariz…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma [Phase 2]
Phase 2 study update of the HDAC inhibitor quisinostat in previously treated Cutaneous T-Cell Lymphoma (Stage Ib-IVa) has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Everolimus in Treating Cutaneous T-cell Lymphoma [Phase 2]
A Phase 2 trial of everolimus for cutaneous T-cell lymphoma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma [Phase 2]
This clinical trial update discusses a Phase 2 study of SHAPE in IA, IB or IIA Cutaneous T-Cell Lymphoma assessing efficacy, safety and tole…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
This clinical trial update reports termination of the study NCT01556828, which analyzed cutaneous and hematologic disorders using high-throu…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Early Diagnosis of Mycosis Fungoides [NA]
The document provides an update on a clinical trial investigating early diagnosis of mycosis fungoides, a form of cutaneous T-cell lymphoma,…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL) [Phase 1]
Phase 1 study of CD5789 in early cutaneous T-cell lymphoma (CTCL) has completed its Phase 1 portion.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL) [Phase 1]
Phase 1 study assessing safety, pharmacodynamics, and pharmacokinetics of SHP141 in patients with cutaneous T-cell lymphoma (CTCL); results …
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Long-term Use of Romidepsin in Patients With CTCL
Clinical trial update on long-term use of romidepsin in patients with cutaneous T-cell lymphoma. The study is completed and sponsored by Nor…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL [Phase 2]
A Phase 2 trial investigating a combination of bexarotene and rosiglitazone for cutaneous T-cell lymphoma has been completed, with results p…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma [Phase 2]
Phase 2 trial of bortezomib for relapsed or refractory cutaneous T-cell lymphoma has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma [Phase 2]
A Phase 2 study evaluated depsipeptide (romidepsin) for cutaneous T-cell lymphoma and peripheral T-cell lymphoma. The trial has completed wi…
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with recurrent aggressive non-Hodgkin lymphomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating APO866 for Cutaneous T-cell Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Effect of Denileukin Diftitox on Immune System in CTCL Patients
This completed trial update reports on the effects of denileukin diftitox on the immune system in patients with cutaneous T-cell lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Immunization Against Tumor Cells in Sezary Syndrome [Phase 2]
Status update indicates the completion of a Phase 2 clinical trial evaluating an immunization against tumor cells in Sézary syndrome (cutane…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial assessed the combination of O6-Benzylguanine with topical Carmustine in patients with early-stage cutaneous T-cell lymphom…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated everolimus (RAD001) in combination with CHOP chemotherapy for newly diagnosed peripheral T-cell lymphom…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma [Phase 2]
Phase 2 trial of vorinostat in primary cutaneous T-cell lymphoma was terminated; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of gemcitabine and bexarotene for progressive or refractory cutaneous T-cell lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas [Phase 2]
A Phase II study of PXD101 (belinostat) in recurrent or refractory cutaneous T-cell lymphoma and peripheral T-cell lymphoma was terminated; …
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma [NA]
ClinicalTrials.gov provides an update on using Helical Irradiation of Total Skin (HITS) for treating Cutaneous T-cell Lymphoma. The current …
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a treatment for recalcitrant pruritus in patients with cutaneous T-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides [Phase 2]
This entry provides an update on a Phase 2 trial of combination chemotherapy for advanced or recurrent mycosis fungoides. Mycosis fungoides …